Literature DB >> 8657834

Circadian variation in rat brain AP-1 DNA binding activity after cholinergic stimulation: modulation by lithium.

M B Williams1, R S Jope.   

Abstract

The potential influence of a circadian rhythm and its modulation by lithium on the stimulation of AP-1 DNA binding activity by the cholinergic agonist pilocarpine was investigated in rat cerebral cortex. Stimulation of AP-1 binding after pilocarpine (30 mg/kg) was evident within 1 h and was maximally stimulated by 200% at 2 h. Pilocarpine-stimulated AP-1 binding exhibited a circadian rhythm in AP-1 binding measured at 0800, 1200, and 1600 hours, 2 h after pilocarpine. Pilocarpine-stimulated AP-1 binding at 0800 hours was approximately twice the level measured at 1600 hours. After acute lithium treatment, pilocarpine administration induced generalized seizures after about 20 min and stimulated AP-1 binding which increased continuously for 4.5 h, at which time the stimulation was 900% above control. A circadian variation was apparent in AP-1 binding stimulated by acute lithium plus pilocarpine, with stimulation at 0800 hours being 1.5 times that at 1600 hours. After chronic lithium and pilocarpine, which also produced seizures, there was no circadian variation in pilocarpine-stimulated AP-1 binding. Thus pilocarpine-induced AP-1 binding in rat cerebral cortex was influenced by a circadian rhythm, but this was abolished by chronic lithium administration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8657834     DOI: 10.1007/bf02246267

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  Status epilepticus is produced by administration of cholinergic agonists to lithium-treated rats: comparison with kainic acid.

Authors:  R A Morrisett; R S Jope; O C Snead
Journal:  Exp Neurol       Date:  1987-12       Impact factor: 5.330

Review 2.  Steroids and depression.

Authors:  B E Murphy
Journal:  J Steroid Biochem Mol Biol       Date:  1991-05       Impact factor: 4.292

Review 3.  Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun.

Authors:  J I Morgan; T Curran
Journal:  Annu Rev Neurosci       Date:  1991       Impact factor: 12.449

4.  A cholinergic antagonist, mecamylamine, blocks the phase-shifting effects of light on the circadian rhythm of locomotor activity in the golden hamster.

Authors:  D L Keefe; D J Earnest; D Nelson; J S Takahashi; F W Turek
Journal:  Brain Res       Date:  1987-02-17       Impact factor: 3.252

5.  Effect of light on corticosterone levels in plasma of rats.

Authors:  L E Scheving; J E Pauly
Journal:  Am J Physiol       Date:  1966-05

6.  Effects of chronic lithium treatment on protein kinase C and cyclic AMP-dependent protein phosphorylation.

Authors:  T L Casebolt; R S Jope
Journal:  Biol Psychiatry       Date:  1991-02-01       Impact factor: 13.382

7.  Characterization of lithium potentiation of pilocarpine-induced status epilepticus in rats.

Authors:  R S Jope; R A Morrisett; O C Snead
Journal:  Exp Neurol       Date:  1986-03       Impact factor: 5.330

8.  Diurnal variation in kainate-induced AP-1 activation in rat brain: influence of glucocorticoids.

Authors:  T Unlap; R S Jope
Journal:  Brain Res Mol Brain Res       Date:  1995-02

Review 9.  Rhythms and the pharmacology of lithium.

Authors:  H Klemfuss
Journal:  Pharmacol Ther       Date:  1992       Impact factor: 12.310

10.  Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain.

Authors:  A Peiffer; S Veilleux; N Barden
Journal:  Psychoneuroendocrinology       Date:  1991       Impact factor: 4.905

View more
  2 in total

1.  Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism.

Authors:  Sandra Ghelardoni; Richard P Bazinet; Stanley I Rapoport; Francesca Bosetti
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

Review 2.  The behavioral actions of lithium in rodent models: leads to develop novel therapeutics.

Authors:  Kelley C O'Donnell; Todd D Gould
Journal:  Neurosci Biobehav Rev       Date:  2007-04-13       Impact factor: 8.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.